RAPP (RAPP) Stock Price & Analysis
RAPP (RAPP) fell 3.94% to USD 45.77 as of September 8, 2026 at 05:00 UTC, according to Nexqual real-time market data.
RAPP last closed at USD 45.77; the session ranged USD 45.53–48 on volume of 279,884 shares. Market capitalization is —, with a 52-week range of USD 22.06–52.93 (NGM). Source: Nexqual, September 8, 2026 at 05:00 UTC.
Key Statistics (as of September 8, 2026 at 05:00 UTC)
| Price | USD 45.77 |
|---|---|
| Change | ▼ 3.94% (down) |
| Previous Close | USD 45.77 |
| Open | USD 45.77 |
| Day Range | USD 45.53 – 48 |
| 52-Week Range | USD 22.06 – 52.93 |
| Volume | 279,884 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (RAPP)
Nexqual's technical model rates RAPP "BUY" based on 4 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 05:00 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 44.36 (neutral) |
| vs SMA50 | Above (USD 44.29) |
| MACD | 1.1 (positive) |
From RAPP's Latest SEC 10-K Filing (filed 2026-03-10)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MBX | MBX Biosciences, Inc. | USD 61.72 | ▲ 1.36% |
| MLYS | Mineralys Therapeutics, Inc. | USD 28.21 | ▼ 2.86% |
| BCAX | Bicara Therapeutics Inc. | USD 23.17 | ▼ 1.66% |
| ALMS | Alumis Inc. | USD 11.1 | ▲ 7.25% |
| AVBP | ArriVent BioPharma, Inc. | USD 30.95 | ▲ 1.44% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:00 UTC. This page is informational and not investment advice.